Industry-Leading Pulse Oximetry Platform Now Features First-of-Its-Kind Atrial Fibrillation (AFib) Detection with Previously ...
Although use of pulse oximetry in hospitalized children with respiratory infections is common, the data supporting its use are limited. Recommendations from the American Academy of Pediatrics in 2006 ...
DENVER, Nov. 01, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc. a continuous health monitoring and clinical intelligence company, today announced the launch of its patented, FDA-cleared, pulse ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the full market release of the Masimo W1™ health watch for consumer use. The first of its kind, the Masimo W1 offers accurate, ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...
Masimo, a medical device maker known for its innovations in oxygen saturation (SpO2) monitoring, has received FDA 501(k) clearance for the Masimo W1 smartwatch, allowing it to be sold in America. This ...
Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) ...
James Mault, MD, founder and CEO of BioIntelliSense, has had, in his words, “an extraordinarily rewarding personal and professional journey” both in practicing medicine as a physician, and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results